BJcuL, a lectin purified from Bothrops jararacussu venom, induces apoptosis in human gastric carcinoma cells accompanied by inhibition of cell adhesion and actin cytoskeleton disassembly by Nolte, Stefanie et al.
  Universidade de São Paulo
 
2012
 
BJcuL, a lectin purified from Bothrops
jararacussu venom, induces apoptosis in
human gastric carcinoma cells accompanied
by inhibition of cell adhesion and actin
cytoskeleton disassembly
 
 
TOXICON, OXFORD, v. 59, n. 1,pp. 81-85, JAN, 2012
http://www.producao.usp.br/handle/BDPI/42040
 
Downloaded from: Biblioteca Digital da Produção Intelectual - BDPI, Universidade de São Paulo
Biblioteca Digital da Produção Intelectual - BDPI
Departamento de Biologia Celular e Molecular e Bioagentes
Patogênicos - FMRP/RBP
Artigos e Materiais de Revistas Científicas - FMRP/RBP
Short communication
BJcuL, a lectin puriﬁed from Bothrops jararacussu venom, induces
apoptosis in human gastric carcinoma cells accompanied by inhibition
of cell adhesion and actin cytoskeleton disassembly
Stefanie Nolte a, Danusa de Castro Damasio a, Adriana Cristina Baréa a, Joana Gomes b,
Ana Magalhães b, Luciana FC Mello Zischler c, Patrícia M Stuelp-Campelo d,
Selene L Elíﬁo-Esposito a, Maria Cristina Roque-Barreira e, Celso A Reis b,
Andréa Novais Moreno-Amaral a,*
aGroup for Advanced Molecular Investigation, PPGCS/CCBS, PUCPR, 80215-901 Curitiba, Paraná, Brazil
b Institute of Molecular Pathology and Immunology of the University of Porto, IPATIMUP, 4200-465 Porto, Portugal
cBiology Course, PUCPR, 80215-901 Curitiba, Paraná, Brazil
d Pharmacy Course, PUCPR, 80215-901 Curitiba, Paraná, Brazil
eDepartment of Cellular and Molecular Biology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, USP, 14049-900 São Paulo, Brazil
a r t i c l e i n f o
Article history:
Received 19 July 2011
Received in revised form 20 October 2011
Accepted 27 October 2011
Available online 4 November 2011
Keywords:
BJcuL
Bothrops jararacussu
Apoptosis
Antitumor activity
Gastric carcinoma
a b s t r a c t
We show that BJcuL, a lectin puriﬁed from Bothrops jararacussu venom, exerts cytotoxic
effects to gastric carcinoma cells MKN45 and AGS. This effect was due to the direct
interaction with speciﬁc glycans on the cells surface and was observed by cell viability
decrease, disorganization of actin ﬁlaments and apoptosis. In addition, BJcuL was able to
reduce tumor cell adhesion to matrigel, what was inhibited by speciﬁc carbohydrate or
partially inhibited when cells were pre-incubated with matrigel. Our results suggest that
BJcuL was able to promote apoptosis in both tumor cells lines and therefore has a prospect
for potential use in cancer therapy.
 2011 Elsevier Ltd. All rights reserved.
The venom of Bothrops jararacussu contains a lectin,
called BJcuL, characterized as a C-type lectin with high
afﬁnity for ß-D-galactosides (de Carvalho et al., 1998).
When biologically assayed, BJcuL has showed to promote
edema and increased vascular permeability in the hind
paws of mice (Panunto et al., 2006), which may induce
a direct cellular inﬁltration by creating an adhesive surface
for leukocyte rolling (Eliﬁo-Esposito et al., 2007). Recently,
we have shown that BJcuL could recognize glycoligands on
the neutrophil surface and induce potent human
neutrophils activation observed by polarization, migration
and adhesion to extracellular matrix (ECM). Also, BJcuL
induced neutrophil functional activation observed by
phagocytic uptake, superoxide production and delay in cell
apoptosis (Eliﬁo-Esposito et al., 2011). Furthermore, like
other venom lectins, BJcuLwas also particularly cytotoxic to
different tumor cell lines (de Carvalho et al., 2001), but the
initial mechanisms of this effect had not yet been
described.
In the present work BJcuL was puriﬁed from the crude
venom by afﬁnity chromatography on an agarose-D-galac-
tose column as previously described (Eliﬁo-Esposito et al.,
2007) and biotinylated according to the manufacturer’s
recommendations. Using biotinyl-BJcuL, we observed that
the lectin was evenly bound on the human gastric
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carcinoma MKN45 and AGS cells surface (Fig. 1A and B,
respectively) and this interaction was abolished in the
presence of the BJcuL speciﬁc ligand (D-Gal) (Fig. 1C), while
a non-speciﬁc monosaccharide (GlcNAc) did not affect the
lectin binding (Fig. 1C). No labeling was detected when the
cells were submitted to a similar process inwhich the lectin
was absent (control cells) (Fig. 1C).
Complex carbohydrate structures expressed by cells
have potential for encoding information in recognition
processes. Carbohydrates are differentiation markers and
antigenic determinants (Feizi and Childs, 1987) and lectins
are proteins that decode this speciﬁcity. It appears that the
binding due to carbohydrate recognition domain (CRD) is
a prerequisite for BJcuL cytotoxic effect (Fig. 1E), since the
Fig. 1. Cell-bound BJcuL is dependent on the carbohydrate recognition and promotes cytotoxicity and adhesion inhibition. (A–C) Cells adhering to coverslips were
ﬁxed with 2% paraformaldehyde, washed and then incubated with 1% H2O2/methanol for 10 min at room temperature (RT). After rinsing, cells were incubated
with 5 mg/ml biotinyl-BJcuL, for 2 h at RT and this binding was revealed by incubation with avidin-FITC conjugate for 45 min. Images were provided by a Leica
DMBL microscope (Leica Microsystems), captured by a Digital Microscope Camera (Polaroid). Quantiﬁcation of bound-BJcuL on the cell surface was obtained with
the Image-Pro Plus Software (Media Cybernetics). (D–E) The cytotoxic effect of BJcuL was evaluated by MTT assay. Cells (1  104 cells/well) were incubated for
24 h at 37 C with different concentrations of BJcuL (0.625; 1.25; 1.8 and 2.5 mg/ml in 5% RPMI). After that, 10 ml of the MTT solution (5 mg/ml) were added for
more 3 h-incubation and reaction was stopped by the addition of DMSO. The optical density (OD) was measured at 570 nm. (F) Tumor cells suspension (1  104
cells/well) in 5% RPMI, containing or not BJcuL (2.5 mg/ml), was distributed in matrigel-coated wells, and incubated for 24 h at 37 C. (G) Tumor cells were
distributed in the matrigel-coated wells and incubated for 1 h at 37 C to promote cell adherence. After that, BJcuL was added for further 24 h incubation. For both
protocols (F–G), the cells supernatants were carefully transferred to a fresh plate and submitted to additional 24 h incubation at 37 C for cell viability analysis.
Cells that remained adhered to the matrigel-coated wells were analyzed by MTT assay. For all experiment, negative control cells were incubated only with 5%
RPMI and for inhibition assays the lectin was pre-incubated for 45 min at 37 C with 2 mM Gal or 2 mM GlcNAc. Data represent means  SD. Statistical differences
were determined by Student t-test (**p < 0.01 and *p < 0.05).
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lectin showed a dose-dependent cytotoxic activity in both
tumor cells (Fig. 1D) after 24 h incubation. The lowest dose
evaluated (0.625 mg/ml) promoted a 50% decrease in cell
viability, which was progressively reduced to 80% in the
highest doses (2.5 and 5 mg/ml). Because of this result we
chose the concentration of 2.5 mg/ml for the other biolog-
ical assays. Furthermore, carcinoma cells were highly
adherent to the matrigel-coated wells, but the incubation
with BJcuL inhibited by 74% and 83% the adhesion of
MKN45 and AGS cells, respectively (Fig. 1F). Non-adhered
cells, collected in the supernatant of cultures, were not
viable, as revealed by microscopic analysis (not shown).
When cells were incubated with matrigel-coated wells 1 h
before the lectin was added, the strong inhibition showed
in Fig. 1F was decreased to 42% and 55%, respectively
(Fig.1G). Again, inhibition of cells adherence determined by
BJcuL was selectively reverted in the speciﬁc carbohydrate
presence (Fig. 1G). These results suggests that glycosylated
molecules that abound in the ECM may contain targets for
BJcuL recognition and so interfere in the lectin activity or
that lectin binding sites on the cancer cells may be blocked
sterically in the already adherent cells. The effect of BJcuL
on cell adhesion was not observed by de Carvalho et al.
(2001), who demonstrated that BJcuL was not able to
inhibit human metastatic breast cell (MDA-MB-435 cell
line) and human ovarian carcinoma (OVCAR-5) adhesion to
ECM proteins such as ﬁbronectin, laminin and collagen
type I.
In order to characterize the effects of BJcuL on the cell
morphology, the cytoskeleton was examined by ﬂuores-
cence microscopy. We observed that MKN45 (Fig. 2A) and
AGS (Fig. 2C) control cells showed a symmetrical distribu-
tion of F-actin around cells with dense meshwork of
polarized actin ﬁlaments in the limit of adjacent cells. BJcuL
caused a signiﬁcant decrease in F-actin in both MKN45
(Fig. 2B) and AGS (Fig. 2D) cells, in comparison to control
cells. Actin ﬁlaments of both tumor cells began to shrink
into the center at cellular focal contacts and were
completely disassembled, resulting in decreased ﬂuores-
cence by FITC-phalloidin conjugate (arrows, Fig. 2B and D,
respectively). The oncogenic transformation is often asso-
ciated with changes in the cytoskeleton organization that
may inﬂuence cell migration, adhesion and invasiveness.
The actin cytoskeleton plays an important role in tumor cell
locomotion through recognition and binding to the ECM
(Hall, 1998; Adams, 2001). In this study, treatment with
BJcuL resulted in complete actin ﬁlament disorganization
and disassembly in MKN45 and AGS tumor cells, as well as
detachment from extracellular matrix. The cytoskeleton is
also involved in apoptotic signaling such as sensitization to
Fas-induced apoptosis by polymerized actin, triggering of
membrane blebbing by acto-myosin contraction, and
Fig. 2. Actin cytoskeleton is disassembled by BJcuL. Glass coverslips were placed in a 24-well plate and MKN45 (A and B) and AGS (C and D) cells (5  104) were
allowed to adhere for 24 h at 37 C. Subsequently, cells were incubated with only 5% RPMI (A and C) or with BJcuL (2.5 mg/ml) (B and D) for 24 h. After washing
twice with PBS, cells were ﬁxed with 4% paraformaldehyde for 20 min at RT and permeabilized with 0.1% Triton X-100 for 5 min. Actin cytoskeleton was stained
with FITC-conjugated phalloidin and the nuclei was stained with DAPI for 30 min at RT, in the dark. Areas with cytoskeleton disassembly are indicated with
arrows. Cells were washed with PBS and then coverslips were inverted on microscope slides and mounted with Vecta-shield medium. The images were obtained
using an Olympus IX70 microscope.
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uptake of apoptotic cells by phagocytes through the acti-
vation of Rac. The cleavage of several cytoskeleton
components by caspases ensures the orderly dismantle-
ment of the dying cell (Ndozangue-Touriguine et al., 2008).
The apoptosis of tumor cells was analyzed by degrada-
tion of nuclear DNA. Mostly MKN45 or AGS tumor cells
incubated with of BJcuL (2.5 mg/ml) have incorporated
ﬂuorescein-12-dUTP (light blue ﬂuorescence) which labels
DNA fragments in apoptotic cells (arrows, Fig. 3B and D,
respectively), whereas only few dark blue staining cells,
counterstained with DAPI, were detected. On the other
hand, untreated MKN45 and AGS cells were mainly dark
blue indicating non-apoptotic cells (arrowheads, Fig. 3A
and C). Apoptosis is an intrinsic cell death mechanism that
plays an important role in the maintenance of healthy
tissue and is characterized by cell contraction, chromatin
condensation, DNA fragmentation, and activation of cas-
pases (Salvesen and Dixit, 1997). Therefore, searching for
agents that trigger apoptosis of tumor cells has become an
attractive strategy in anticancer drug discovery (Reed,
2003; Liu et al., 2009a, 2009b). One of the major ﬁndings
in this study is that BJcuL induced apoptotic cell death in
gastric carcinomaMKN45 and AGS cell lines, as reported by
other lectins. The Viscum album agglutinin-I (VAA-I) and
WGA were able to induce apoptosis in various tumor cells
(Gastman et al., 2004). ConA and PCL (Phaseolus coccineus
lectin) induced apoptosis in tumor cells in a caspase-
dependent manner (Liu et al., 2009a) like as the
Polygonatum odoratum lectin that increased the activity of
caspase-3, -8 and -9 in a time-dependentmanner (Liu et al.,
2009b).
The antitumoral properties of lectins have been demon-
strated invivoand invitroandsuggests apotential clinical use
in slowing tumor progression by cytotoxicity, apoptosis, and
inhibition of tumor growth (De Mejia and Prisecaru, 2005).
VAA-Iwas introduced in the treatment of cancer in 1917, and
today has still been used in adjuvant cancer therapy in
several European countries. It seems that mistletoe extracts
stimulate the immune system, enhance the cytotoxic effect
of chemotherapeutic drugs, improve survival and quality of
life, and reduce adverse effects of chemo- and radiotherapy
in cancer patients (Salzer,1981; Olsnes et al.,1982; Horneber
et al., 2008). BJcuL (deCarvalho et al., 2001), CEL-I andCEL-III
(lectins from marine invertebrate Cucumis echinata)
(Kuramoto et al., 2005),WGA (Ohba et al., 2003), Con A (Kim
et al., 1993) and others, are known to bind on tumor cells
membranes, affecting cell viability. We have recently re-
ported that BJcuL is capable of inducing potent neutrophil
activation without exerting cytotoxicity (Eliﬁo-Esposito
et al., 2011). Other authors have proposed that lectins have
the ability to distinguish normal from malignant cells
(Sharon and Lis, 1995; Sabova et al., 2010) and for that have
different toxic abilities that can be due to different glycans
expressed on the surface of these cells (Miller et al., 1973;
Matsuda et al., 2010). There are lectins that interact
strongly with leukemia cells, triggering agglutination and
Fig. 3. BJcuL promote tumor cells apoptosis. Representative photomicrographs showing labeling of DNA strand breaks associated with apoptosis assayed by
terminal deoxynucleotidyl tranferase-mediated dUTP nick end-labeling (TUNEL) method. Tumor cells were seeded onto coverslips and (A) MKN45 and (C) AGS
cells were incubated only with 5% RPMI and (B) MKN45 or (D) AGS cells were incubated with BJcuL (2.5 mg/ml) for 24 h at 37 C. For apoptosis evaluation, after
incubation, adherent cells on coverslips were processed using a TdT FragEL-DNA fragmentation detection kit (Calbiochem-Oncogene). Arrows show apoptotic
cells and arrowheads, the DAPI staining.
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cytotoxicity, but exert no effect on normal lymphocytes
(Ohba and Bakalova, 2003).
This study conﬁrmed the cytotoxicity of BJcuL to tumor
cells mainly by altering cell adhesion and inducing
apoptosis. Therefore, we suggest that BJcuL may compete
for binding to the cell surface with ECM glycoproteins and
promote the actin disassembles and could possibly accel-
erate cellular detachment from the ECM. Consequently
BJcuL interaction with glycoligands on the tumor cell
surface may induce the activation of intracellular signals
capable to inhibit cell proliferation, leading to apoptosis.
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